Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications

Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications

Introduction: Cetuximab-based chemotherapy showed a statistically significantly higher response rate compared with chemotherapy such as FOLFOX. Therefore, FOLFOX plus cetuximab is suspected to be the best regimen to alleviate tumor-related symptoms with a high response rate. Case Report: Here we pre...

Full description

Bibliographic Details
Main Authors: Kohei Shitara, Tomoya Yokota, Daisuke Takahari, Takashi Shibata, Yozo Sato, Masahiro Tajika, Takashi Ura, Kei Muro
Format: Article
Language:English
Published: Karger Publishers 2010-07-01
Series:Case Reports in Oncology
Subjects:
Colorectal cancer
Poor performance status
FOLFOX
Cetuximab
Online Access:http://www.karger.com/Article/FullText/319474

Internet

http://www.karger.com/Article/FullText/319474

Similar Items